Evaluation of SARS-CoV-2 ORF7a Deletions from COVID-19-Positive Individuals and Its Impact on Virus Spread in Cell Culture

Viruses. 2023 Mar 21;15(3):801. doi: 10.3390/v15030801.

Abstract

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the COVID-19 outbreak, posed a primary concern of public health worldwide. The most common changes in SARS-CoV-2 are single nucleotide substitutions, also reported insertions and deletions. This work investigates the presence of SARS-CoV-2 ORF7a deletions identified in COVID-19-positive individuals. Sequencing of SARS-CoV-2 complete genomes showed three different ORF7a size deletions (190-nt, 339-nt and 365-nt). Deletions were confirmed through Sanger sequencing. The ORF7a∆190 was detected in a group of five relatives with mild symptoms of COVID-19, and the ORF7a∆339 and ORF7a∆365 in a couple of co-workers. These deletions did not affect subgenomic RNAs (sgRNA) production downstream of ORF7a. Still, fragments associated with sgRNA of genes upstream of ORF7a showed a decrease in size when corresponding to samples with deletions. In silico analysis suggests that the deletions impair protein proper function; however, isolated viruses with partial deletion of ORF7a can replicate in culture cells similarly to wild-type viruses at 24 hpi, but with less infectious particles after 48 hpi. These findings on deleted ORF7a accessory protein gene, contribute to understanding SARS-CoV-2 phenotypes such as replication, immune evasion and evolutionary fitness as well insights into the role of SARS-CoV-2_ORF7a in the mechanism of virus-host interactions.

Keywords: B.1.1.33 lineage; COVID-19; ORF7a; SARS-CoV-2; sgRNAs; viral fitness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Cell Culture Techniques
  • Humans
  • SARS-CoV-2* / genetics
  • Sequence Analysis
  • Sequence Deletion
  • Subgenomic RNA / genetics
  • Viral Proteins* / genetics

Substances

  • ORF7a protein, SARS-CoV-2
  • Viral Proteins
  • Subgenomic RNA

Grants and funding

Rosane Silva (Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro—FAPERJ): E-26/200.999/2022; SEI-260003/012994/2021; SEI-260003/001129/2020; (Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPQ): 303.829/2019-2; Maria Clara da Costa Simas (Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior—Capes): 88887.511767/2020-00 and Sara Mesquita Costa (Capes): 88887.647891/2021-00.